Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Clarithromycin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Idiopathic hypersomnia === Clarithromycin has been researched as a potential treatment for [[idiopathic hypersomnia]] (IH) in adults, but the evidence is limited. A 2021 [[Cochrane (organisation)|Cochrane]] study determined that the evidence is inadequate to definitively determine the efficacy of clarithromycin in the management of idiopathic hypersomnia.<ref name="pmid34031871">{{cite journal |vauthors=Trotti LM, Becker LA, Friederich Murray C, Hoque R |title=Medications for daytime sleepiness in individuals with idiopathic hypersomnia |journal=The Cochrane Database of Systematic Reviews |volume=2021 |issue=5 |pages=CD012714 |date=May 2021 |pmid=34031871 |pmc=8144933 |doi=10.1002/14651858.CD012714.pub2 |quote=There is insufficient evidence to conclude whether clarithromycin is effective for the treatment of idiopathic hypersomnia.}}</ref> The [[American Academy of Sleep Medicine|American Academy of Sleep Medicine's]] 2021 clinical practice guidelines conditionally suggested its use, especially for those who don't respond to other therapies.<ref name="pmid34743789">{{cite journal |vauthors=Maski K, Trotti LM, Kotagal S, Robert Auger R, Rowley JA, Hashmi SD, Watson NF |title=Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline |journal=Journal of Clinical Sleep Medicine |volume=17 |issue=9 |pages=1881β1893 |date=September 2021 |pmid=34743789 |pmc=8636351 |doi=10.5664/jcsm.9328 |quote=Recommendation 9: We suggest that clinicians use clarithromycin (vs no treatment) for the treatment of idiopathic hypersomnia in adults. (CONDITIONAL)}}</ref><ref name="AASM GAG">{{cite web |title=Treatment of Central Disorders of Hypersomnolence: An American Academy of Sleep Medicine Clinical Practice Guideline - Guidelines at a Glance |url=https://aasm.org/wp-content/uploads/2022/03/Treatment_Central_Disorders_Hypersomnolence_Guideline_at_a_Glance.pdf |publisher=American Academy of Sleep Medicine |access-date=25 February 2024 |archive-url=https://web.archive.org/web/20240225104203/https://aasm.org/wp-content/uploads/2022/03/Treatment_Central_Disorders_Hypersomnolence_Guideline_at_a_Glance.pdf |archive-date=25 February 2024 |date=2021 |url-status=live}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)